Investor · Seattle, WA
John Mulligan
Open John in the network graph →Filings
22
SEC Form D
Connections
79
co-filers
Capital
$39.6M
across filings
Active
Dec 2017
to May 2020
Most-connected co-filers (79)
Karl Handelsman · Seattle, WA11 sharedNicholas Walrod · TEMPE, AZ11 sharedMonique Schiersing · Seattle, WA9 sharedMitchell W. Mutz · Pleasanton, CA7 sharedJohn P. Mckearn · St. Louis, MO6 sharedMary E. Alexander · FAYETTEVILLE, AR6 sharedAir Life Fund Management Qp, Llc · Chicago, IL6 sharedAir Life Fund Management Qp, Llc · Chicago, IL6 sharedStephen C. Malloy · FAYETTEVILLE, AR6 sharedStephen Luongo · Chicago, IL6 sharedMatthew Schaefer · Chicago, IL6 sharedRichard Beleutz · Chicago, IL6 sharedBenjamin N. Blanchard · Montgomery, AL6 sharedAlmitas Capital Llc · Santa Monica, CA4 sharedAlmitas Capital Llc · Pacific Palisades, CA4 sharedPhillip Clegg · New York, NY4 sharedBradley D. Fisher · MINNEAPOLIS, MN3 sharedPhilip E. Vorobeychik · New York, NY3 sharedHong Yu · Holliston, MA3 sharedJennings J. Newcom · RADNOR, PA3 sharedGeoffrey C. Nicholson · St. Paul, MN3 sharedJames Shmerling · Holliston, MA3 sharedWilliam J. Devers, Jr · CHICAGO, IL3 sharedJen A. Wilson · Minneapolis, MN3 shared
Recent filings (22)
AIR U.S. Life Fund II QP, LPJul 2025 · 10 co-filersAIR U.S. Life Fund II QP, LPJul 2024 · 10 co-filersAIR U.S. Life Fund II QP, LPJul 2023 · 10 co-filersBonum Therapeutics, Inc.Nov 2022 · 24 co-filers$93.0MAIR U.S. Life Fund II QP, LPJul 2022 · 10 co-filersBonum Therapeutics, Inc.Dec 2021 · 20 co-filers$3.6MGood Therapeutics, Inc.Dec 2021 · 13 co-filers$26.4MGood Therapeutics, Inc.Dec 2021 · 13 co-filers$26.4MAIR U.S. Life Fund II QP, LPJul 2021 · 10 co-filersAlmitas Opportunity Fund LPJul 2020 · 5 co-filersAIR U.S. Life Fund II QP, LPJul 2020 · 10 co-filersGood Therapeutics, Inc.May 2020 · 14 co-filers$22.3MAlmitas Opportunity Fund LPJul 2019 · 3 co-filersGood Therapeutics, Inc.Feb 2019 · 14 co-filers$22.3MGood Therapeutics, Inc.Nov 2018 · 11 co-filers$18.0MAlmitas Opportunity Fund LPJul 2018 · 3 co-filersSupira Medical, Inc.May 2018 · 11 co-filers$12.9MThrivent White Rose Fund XI Fund of Funds, LPDec 2017 · 26 co-filers$600.0MSupira Medical, Inc.Dec 2017 · 8 co-filers$2.0MThrivent White Rose GP XI, LLCDec 2017 · 26 co-filers$2.1MThrivent White Rose Fund XI Equity Direct, L.P.Dec 2017 · 26 co-filers$300.0MAlmitas Opportunity Fund LPJul 2017 · 3 co-filersGlycostasis, Inc.Jun 2015 · 1 co-filer$2.7MGlycostasis, Inc.Jun 2015 · 1 co-filer$2.7M
Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See John in the interactive graph →